| Dr Brennan Thomas Dodson, MD | |
|
1648 Ellis Street, Suite 301, Bozeman, MT 59715-8811 | |
| (406) 556-9798 | |
| (406) 556-9795 |
| Full Name | Dr Brennan Thomas Dodson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 23 Years |
| Location | 1648 Ellis Street, Suite 301, Bozeman, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518936533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 44270 (Colorado) | Secondary |
| 207Y00000X | Otolaryngology | 11061 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bridger Ear, Nose And Throat Pllc | 7315950037 | 3 |
News Archive
Conceptus Inc., developer of the Essure(R) procedure, the first and proven non-surgical permanent birth control method, announced today that the third generation (ESS305) of the Essure procedure has received FDA-approval for an improved bilateral placement rate of 96.9%. Improvement in the hysteroscopic time of 9 minutes is an additional benefit.
Eight years after being treated with a new drug for non-Hodgkin's lymphoma, 86 percent of patients were still alive and half had not had a relapse of their disease, according to researchers from the University of Michigan Comprehensive Cancer Center.
Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.
A letrozole pill once a week restored fertility in obese, infertile men and led to their partners giving birth to two full-term, healthy babies, according to a new study from Canada. The results will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 3 days ago
| Entity Name | Bridger Ear, Nose And Throat Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407878549 PECOS PAC ID: 7315950037 Enrollment ID: O20060725000431 |
News Archive
Conceptus Inc., developer of the Essure(R) procedure, the first and proven non-surgical permanent birth control method, announced today that the third generation (ESS305) of the Essure procedure has received FDA-approval for an improved bilateral placement rate of 96.9%. Improvement in the hysteroscopic time of 9 minutes is an additional benefit.
Eight years after being treated with a new drug for non-Hodgkin's lymphoma, 86 percent of patients were still alive and half had not had a relapse of their disease, according to researchers from the University of Michigan Comprehensive Cancer Center.
Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.
A letrozole pill once a week restored fertility in obese, infertile men and led to their partners giving birth to two full-term, healthy babies, according to a new study from Canada. The results will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brennan Thomas Dodson, MD 1648 Ellis Street, Suite 301, Bozeman, MT 59715-8811 Ph: (406) 556-9798 | Dr Brennan Thomas Dodson, MD 1648 Ellis Street, Suite 301, Bozeman, MT 59715-8811 Ph: (406) 556-9798 |
News Archive
Conceptus Inc., developer of the Essure(R) procedure, the first and proven non-surgical permanent birth control method, announced today that the third generation (ESS305) of the Essure procedure has received FDA-approval for an improved bilateral placement rate of 96.9%. Improvement in the hysteroscopic time of 9 minutes is an additional benefit.
Eight years after being treated with a new drug for non-Hodgkin's lymphoma, 86 percent of patients were still alive and half had not had a relapse of their disease, according to researchers from the University of Michigan Comprehensive Cancer Center.
Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.
A letrozole pill once a week restored fertility in obese, infertile men and led to their partners giving birth to two full-term, healthy babies, according to a new study from Canada. The results will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 3 days ago
Matthew E Wolpoe, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 288 W Haley Springs Rd Ste 2a, Bozeman, MT 59718 Phone: 406-281-4392 | |
Dr. Hugh Elliott Hetherington, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Highland Blvd Ste 1160, Bozeman, MT 59715 Phone: 406-414-3780 | |
Amanda Kull, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 1648 Ellis St Ste 301, Bozeman, MT 59715 Phone: 406-556-9798 Fax: 406-556-9795 |